News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
690,766 Results
Type
Article (39289)
Company Profile (248)
Press Release (651229)
Section
Business (203979)
Career Advice (2002)
Deals (35396)
Drug Delivery (89)
Drug Development (80909)
Employer Resources (169)
FDA (16120)
Job Trends (14820)
News (344788)
Policy (32464)
Tag
Academia (2531)
Alliances (49285)
Alzheimer's disease (1299)
Approvals (16089)
Artificial intelligence (179)
Bankruptcy (354)
Best Places to Work (11621)
Biotechnology (175)
Breast cancer (214)
Cancer (1588)
Cardiovascular disease (122)
Career advice (1667)
CAR-T (111)
Cell therapy (322)
Clinical research (65043)
Collaboration (606)
Compensation (313)
COVID-19 (2555)
C-suite (141)
Data (1510)
Diabetes (194)
Diagnostics (6234)
Earnings (85127)
Employer resources (146)
Events (110518)
Executive appointments (516)
FDA (16936)
Funding (548)
Gene therapy (223)
GLP-1 (633)
Government (4348)
Healthcare (18741)
Infectious disease (2653)
Inflammatory bowel disease (114)
Interviews (309)
IPO (16421)
Job creations (3626)
Job search strategy (1419)
Layoffs (430)
Legal (7877)
Lung cancer (234)
Manufacturing (221)
Medical device (13244)
Medtech (13249)
Mergers & acquisitions (19281)
Metabolic disorders (513)
Neuroscience (1677)
NextGen: Class of 2025 (6507)
Non-profit (4473)
Northern California (1921)
Obesity (293)
Opinion (188)
Patents (138)
People (56712)
Phase I (20249)
Phase II (28645)
Phase III (21339)
Pipeline (638)
Postmarket research (2562)
Preclinical (8559)
Radiopharmaceuticals (240)
Rare diseases (299)
Real estate (5895)
Regulatory (21829)
Research institute (2311)
Resumes & cover letters (349)
Southern California (1663)
Startups (3567)
United States (17210)
Vaccines (589)
Weight loss (200)
Date
Last 7 days (621)
Last 30 days (2578)
Last 365 days (34648)
2025 (2650)
2024 (35219)
2023 (40078)
2022 (51174)
2021 (55710)
2020 (54086)
2019 (46541)
2018 (35019)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (206)
Asia (37432)
Australia (6119)
California (4397)
Canada (1603)
China (369)
Colorado (198)
Connecticut (210)
Europe (80182)
Florida (633)
Georgia (154)
Illinois (432)
Indiana (249)
Maryland (697)
Massachusetts (3389)
Michigan (188)
Minnesota (322)
New Jersey (1243)
New York (1266)
North Carolina (798)
Northern California (1921)
Ohio (161)
Pennsylvania (1026)
South America (1093)
Southern California (1663)
Texas (643)
Utah (129)
Washington State (435)
690,766 Results for "asuragen inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Asuragen to Present Novel Clinical Testing Data at AMP 2023 Conference
Bio-Techne Corporation announced that Asuragen, a Bio-Techne brand, will present new data on clinical laboratory testing solutions related to cystic fibrosis variant detection, cancer monitoring, resolving conventionally inaccessible, disease-causing genes, and more at the upcoming meeting of the Association for Molecular Pathology, to be held November 14-18 in Salt Lake City, Utah.
November 2, 2023
·
4 min read
BioMidwest
Asuragen to Showcase Innovative Diagnostic Lab Solutions at AMP 2022 Conference
Bio-Techne Corporation (NASDAQ: TECH) today announced that Asuragen, a Bio-Techne brand, will present its diagnostic lab solutions at the upcoming annual meeting of the Association for Molecular Pathology (AMP), taking place November 1-5 in Phoenix, Ariz.
October 31, 2022
·
3 min read
BioMidwest
BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA
Bio-Techne Corporation (NASDAQ: TECH) today announced that Asuragen, part of Bio-Techne’s Molecular Diagnostics Division, has completed the Class C Certification under the new European Union In Vitro Diagnostic Regulation.
March 22, 2024
·
2 min read
Deals
Bio-Techne Completes Acquisition of Asuragen, Inc.
Bio-Techne Corporation (NASDAQ: TECH) today announced it has completed the acquisition of Asuragen, Inc. The transaction included initial consideration of $215 million in cash plus contingent consideration of up to $105 million upon the achievement of certain future milestones.
April 6, 2021
·
2 min read
Press Releases
Exicure, Inc. Announces Purchase Agreement with GPCR Therapeutics Inc.
January 23, 2025
·
5 min read
Press Releases
Kronos Advanced Technologies Inc. ($KNOS) Confirms Ownership and Shareholder Updates for KronosMD, Inc.
January 27, 2025
·
13 min read
BioMidwest
Asuragen Launches New Kit to Enable Broader Coverage of Gene Variants Linked to Cystic Fibrosis
Bio-Techne Corporation announced that Asuragen, Inc., a Bio-Techne brand, has launched a new kit to detect pathogenic variants in the CFTR gene.
November 8, 2021
·
3 min read
Press Releases
Telix Completes Acquisition of RLS (USA) Inc.
January 27, 2025
·
8 min read
Press Releases
Vincerx Pharma, Inc. and Oqory, Inc. Highlight Promising Data for Oqory’s TROP2 Antibody Drug Conjugate, OQY-3258
January 29, 2025
·
13 min read
Press Releases
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Execute Agreement for $27 Million Funding Transaction for HOPE Clinic Acquisition
January 28, 2025
·
8 min read
1 of 69,077
Next
